Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

1,005 Shares in Ebix Inc (NASDAQ:EBIX) Purchased by Emerald Advisers LLC

researchsnappy by researchsnappy
February 2, 2020
in Investment Research
0
Ebix (NASDAQ:EBIX) PT Lowered to $32.92 at S&P Equity Research
400
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

Ebix logoEmerald Advisers LLC purchased a new position in Ebix Inc (NASDAQ:EBIX) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,005 shares of the technology company’s stock, valued at approximately $34,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Tower Research Capital LLC TRC lifted its holdings in shares of Ebix by 228.1% during the 3rd quarter. Tower Research Capital LLC TRC now owns 935 shares of the technology company’s stock worth $39,000 after acquiring an additional 650 shares during the period. Boston Partners acquired a new position in Ebix during the third quarter worth approximately $204,000. Magnus Financial Group LLC purchased a new position in Ebix during the fourth quarter worth approximately $237,000. Voloridge Investment Management LLC purchased a new position in Ebix during the third quarter worth approximately $311,000. Finally, Oppenheimer Asset Management Inc. raised its stake in Ebix by 25.1% during the third quarter. Oppenheimer Asset Management Inc. now owns 8,253 shares of the technology company’s stock worth $347,000 after purchasing an additional 1,658 shares during the period. Institutional investors own 76.77% of the company’s stock.

NASDAQ:EBIX opened at $34.43 on Friday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of 12.66 and a beta of 1.34. The firm’s fifty day simple moving average is $33.69 and its 200 day simple moving average is $37.87. Ebix Inc has a twelve month low of $31.06 and a twelve month high of $63.89.

Ebix (NASDAQ:EBIX) last issued its earnings results on Tuesday, November 12th. The technology company reported $0.67 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.08 by ($0.41). Ebix had a return on equity of 22.39% and a net margin of 14.64%. The company had revenue of $147.20 million during the quarter, compared to analysts’ expectations of $149.43 million. During the same period in the previous year, the company earned $0.92 EPS. Ebix’s quarterly revenue was up 14.5% on a year-over-year basis.

In other Ebix news, Director Hans Ueli Keller bought 1,000 shares of the stock in a transaction dated Thursday, November 21st. The stock was bought at an average cost of $32.83 per share, for a total transaction of $32,830.00. Following the completion of the purchase, the director now directly owns 17,428 shares of the company’s stock, valued at $572,161.24. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 14.20% of the stock is owned by company insiders.

Several analysts have recently issued reports on EBIX shares. Craig Hallum reissued a “buy” rating and set a $110.00 price objective on shares of Ebix in a research note on Tuesday, November 12th. BMO Capital Markets reduced their target price on Ebix from $50.00 to $46.00 and set a “market perform” rating on the stock in a report on Wednesday, November 13th. BidaskClub raised Ebix from a “strong sell” rating to a “sell” rating in a research report on Thursday, January 16th. Finally, S&P Equity Research lowered their price target on Ebix from $34.59 to $32.92 in a research report on Friday, November 15th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $62.97.

Ebix Profile

Ebix, Inc provides software and e-commerce solutions to insurance, finance, healthcare, and e-learning industries. It offers software development, customization, and consulting services to various entities in the insurance industry, including carriers, brokers, exchanges, and standard making bodies. The company operates data exchanges in the areas of finance, travel, life insurance, annuities, employee health benefits, risk management, workers compensation, insurance underwriting, and property and casualty (P&C) insurance.

See Also: Learning About the VIX – Volatility Index

Want to see what other hedge funds are holding EBIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ebix Inc (NASDAQ:EBIX).

Institutional Ownership by Quarter for Ebix (NASDAQ:EBIX)

Receive News & Ratings for Ebix Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Ebix and related companies with MarketBeat.com’s FREE daily email newsletter.

Previous Post

Reese’s Take 5 just stole the record for the largest chocolate nut bar from Snickers – FOX 61

Next Post

The Bearish Momentum Is Strong as XLM/USD May Fall Heavily

Next Post
The Bearish Momentum Is Strong as XLM/USD May Fall Heavily

The Bearish Momentum Is Strong as XLM/USD May Fall Heavily

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com